These pharma stocks are trading at their 52-week highs
The current situation of the pandemic has infused an element of greater volatility in the equity market and the performance of the same has been shaky as compared to a previous couple of months. The second wave of COVID-19 has spooked investors and made them wonder what if the markets tend to replicate the performance that it had portrayed during the first wave in the previous year.
However, amidst these prevailing circumstances, the pharma stocks have been depicting handsome performance. Sustaining through this pandemic, pharma companies are the ones, which are witnessing an increase in their revenue as well as the overall business due to production of medicines & vaccines.
Following are the stocks of the pharma companies that have registered fresh 52-week highs between April 20 and April 22, 2021:
|
Company name
|
Market Cap (Rs crore)
|
Latest 52-week high price
|
|
Apollo Hospitals Enterprise Ltd
|
46,450.35
|
3,334
|
|
Cadila Healthcare Ltd
|
56,536.19
|
573.35
|
|
Glenmark Pharmaceuticals Ltd
|
16,013.04
|
589
|
|
Indoco Remedies Ltd
|
2,991.20
|
337
|
|
JB Chemicals & Pharmaceuticals Ltd
|
10,331.46
|
1,355.50
|
|
Morepen Laboratories Ltd
|
2,341.35
|
52.05
|
|
Neuland Laboratories Ltd
|
3,414.87
|
2,840
|
|
Panacea Biotec Ltd
|
1,982.69
|
323.70
|
|
RPG Life Sciences Ltd
|
765.51
|
509.35
|
|
Sun Pharmaceutical Industries Ltd
|
153,617.42
|
659.50
|
|
Vivimed Labs Ltd
|
258.69
|
31.20
|